As of 4:30 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
750,591.00
597,542.00
415,292.00
258,386.00
179,861.00
Cost of Revenue
192,076.00
152,431.00
118,336.00
70,107.00
50,131.00
Gross Profit
558,515.00
445,111.00
296,956.00
188,279.00
129,730.00
Operating Expense
500,539.00
439,715.00
292,501.00
207,021.00
173,916.00
Operating Income
57,976.00
5,396.00
4,455.00
-18,742.00
-44,186.00
Net Non Operating Interest Income Expense
149,234.00
80,441.00
1,029.00
19,471.00
-482.00
Pretax Income
215,894.00
94,521.00
22,314.00
6,665.00
-57,263.00
Tax Provision
11,625.00
2,701.00
3,887.00
-1,487.00
-13,528.00
Net Income Common Stockholders
204,269.00
91,820.00
18,427.00
8,152.00
-43,735.00
Diluted NI Available to Com Stockholders
204,269.00
91,820.00
18,427.00
8,152.00
-43,735.00
Basic EPS
6.60
3.07
0.62
0.28
-1.61
Diluted EPS
6.58
3.07
0.62
0.28
-1.61
Basic Average Shares
31,108.39
29,935.15
29,525.95
28,845.69
27,171.35
Diluted Average Shares
31,205.47
29,935.15
29,525.95
28,936.08
27,354.52
Total Operating Income as Reported
56,767.00
4,187.00
6,409.00
-18,498.00
-45,675.00
Total Expenses
692,615.00
592,146.00
410,837.00
277,128.00
224,047.00
Net Income from Continuing & Discontinued Operation
204,269.00
91,820.00
18,427.00
8,152.00
-43,735.00
Normalized Income
205,216.10
92,790.97
18,644.46
8,184.55
-43,735.00
Interest Income
--
8,850.00
2,123.00
--
80.00
Interest Expense
--
1,190.00
605.00
276.00
361.00
Net Interest Income
149,234.00
80,441.00
1,029.00
19,471.00
-482.00
EBIT
148,291.00
95,711.00
22,919.00
6,941.00
-56,902.00
EBITDA
148,291.00
172,061.00
65,086.00
39,198.00
-26,864.00
Reconciled Cost of Revenue
192,076.00
152,431.00
118,336.00
70,107.00
50,131.00
Reconciled Depreciation
--
76,350.00
42,167.00
32,257.00
30,038.00
Net Income from Continuing Operation Net Minority Interest
204,269.00
91,820.00
18,427.00
8,152.00
-43,735.00
Total Unusual Items Excluding Goodwill
-1,001.00
-1,001.00
-262.00
-41.00
-9,873.00
Total Unusual Items
-1,001.00
-1,001.00
-262.00
-41.00
-9,873.00
Normalized EBITDA
149,292.00
173,062.00
65,348.00
39,239.00
-26,864.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-53.90
-30.03
-44.54
-8.45
--
12/31/2020 - 10/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MCAP.ST MedCap AB (publ)
507.00
-1.17%
LIA.SG LivaNova PLC
48.80
0.00%
DEAR.ST Duearity AB (publ)
0.0154
0.00%
EJXB.DU Elekta AB
5.30
-1.94%
EJX.MU Elekta AB (publ)
5.35
0.00%
VITR.ST Vitrolife AB (publ)
217.60
+1.68%
SEDANA.ST Sedana Medical AB (publ)
10.62
-0.75%
REG1V.HE Revenio Group Oyj
27.76
-2.66%
SECT-B.ST Sectra AB (publ)
270.00
-0.95%
ACARIX.ST Acarix AB (publ)
0.3180
-0.47%